Profiel
Tobias Larsson Agervald is Chief Executive Officer at Guard Therapeutics International AB since 2019 and Director at TE Medical Consulting AB since 2018.
Former roles include Senior Medical Director at Astellas Pharma Global Development, Inc. and Associate Professor at Karolinska Institutet.
Education includes doctorates from the University of Uppsala and Harvard Medical School.
Actieve functies van Tobias Larsson Agervald
| Bedrijven | Functie | Begin |
|---|---|---|
| DISRUPTIVE PHARMA AB | Algemeen Directeur | 15-01-2019 |
TE Medical Consulting AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Tobias Larsson Agervald
| Bedrijven | Functie | Einde |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Tobias Larsson Agervald
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
TE Medical Consulting AB |
















